For randomised clinical trials, the Jadad scale ( To complement the Jadad score, the Cochrane Risk of Bias Tool (RoB 2) ( For observational studies (cohort and case-control), the NewcastleOttawa Scale (NOS) ( Risk of bias was interpreted as follows: i) Low risk: All criteria met or no more than one rated as unclear
Studies indicated that DSIP may protect neuronal cells from excitotoxicity and oxidative stress, making it a valuable compound for researchers investigating neuroprotection mechanisms
Intranasal delivery of DSIP would allow targeted treatment in neurodegenerative diseases of the brain
Safety data from over 900 clinical trial participants demonstrates that AOD-9604 is remarkably well-tolerated with a side effect profile indistinguishable from placebo in most studies
Anyone interested in longevity peptides or epitalon should understand how sublingual delivery fits into the broader bioregulator peptide landscape
Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis